Growth Metrics

Merck (MRK) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to -$283.0 million.

  • Merck's Cash from Investing Activities rose 9263.98% to -$283.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.0 billion, marking a year-over-year increase of 3612.31%. This contributed to the annual value of -$7.7 billion for FY2024, which is 4508.27% up from last year.
  • As of Q3 2025, Merck's Cash from Investing Activities stood at -$283.0 million, which was up 9263.98% from -$770.0 million recorded in Q2 2025.
  • Over the past 5 years, Merck's Cash from Investing Activities peaked at $53.0 million during Q4 2023, and registered a low of -$12.0 billion during Q4 2021.
  • In the last 5 years, Merck's Cash from Investing Activities had a median value of -$1.2 billion in 2022 and averaged -$2.4 billion.
  • As far as peak fluctuations go, Merck's Cash from Investing Activities soared by 10303.2% in 2023, and later tumbled by 282452.83% in 2024.
  • Over the past 5 years, Merck's Cash from Investing Activities (Quarter) stood at -$12.0 billion in 2021, then skyrocketed by 85.49% to -$1.7 billion in 2022, then surged by 103.03% to $53.0 million in 2023, then crashed by 2824.53% to -$1.4 billion in 2024, then skyrocketed by 80.4% to -$283.0 million in 2025.
  • Its last three reported values are -$283.0 million in Q3 2025, -$770.0 million for Q2 2025, and -$1.5 billion during Q1 2025.